Most genetic studies identify genetic variants associated with disease risk or with the mean value of a quantitative trait. More rarely, genetic variants associated with variance heterogeneity are considered. In this study, we have identified such variance single-nucleotide polymorphisms (vSNPs) and examined if these represent biological gene Â gene or gene Â environment interactions or statistical artifacts caused by multiple linked genetic variants influencing the same phenotype. We have performed a genome-wide study, to identify vSNPs associated with variance heterogeneity in DNA methylation levels. Genotype data from over 10 million single-nucleotide polymorphisms (SNPs), and DNA methylation levels at over 430 000 CpG sites, were analyzed in 729 individuals. We identified vSNPs for 7195 CpG sites (P < 9.4 Â 10 À11 ). This is a relatively low number compared to 52 335 CpG sites for which SNPs were associated with mean DNA methylation levels. We further showed that variance heterogeneity between genotypes mainly represents additional, often rare, SNPs in linkage disequilibrium (LD) with the respective vSNP and for some vSNPs, multiple low frequency variants co-segregating with one of the vSNP alleles. Therefore, our results suggest that variance heterogeneity of DNA methylation mainly represents phenotypic effects by multiple SNPs, rather than biological interactions. Such effects may also be important for interpreting variance heterogeneity of more complex clinical phenotypes.
Introduction
During the last years, thousands of genetic variants have been identified to influence different complex human traits including body mass index (BMI) (1), lipid levels (2) and height (3), as well as intermediate phenotypes such as DNA methylation (4), RNA levels (5) and protein levels (6, 7) . However, only a small proportion of the genetic contribution to complex diseases can be explained by the single-nucleotide polymorphisms (SNPs) identified in genome-wide association studies (GWAS). It is likely that part of the remaining genetic contribution to complex traits, what is often referred to as the hidden heritability, can be explained, not only by common variants with very small effects not identified in the GWAS performed till date, but also by gene Â gene and gene Â environment interactions, or by unmeasured rare genetic variants (3) .
GWAS identify SNPs with effects on the risk for disease or that affect the mean value of a quantitative trait. However, it has been shown that SNPs may be associated with variance heterogeneity of a quantitative trait, rather than (or in addition to) differences in the mean value (Fig. 1 ). Such SNPs, commonly referred to as variance or variation single-nucleotide polymorphisms (vSNPs), where one of the alleles is associated with a larger phenotypic variance compared to the other, are rarely investigated in association studies. In Arabidopsis, such vSNPs have been suggested to be as common as SNPs associated with the mean value of a quantitative phenotype (8) . However, in humans the occurrence of vSNPs is relatively unexplored.
Analyses of phenotypic variance heterogeneity between genotypes has been suggested as an approach for detecting gene Â gene (9, 10) or gene Â environment interactions. For example, the FTO variant rs7202116 (11) has been associated with a 7% difference in variance in BMI between individuals that are homozygous for different alleles. This may reflect that individuals carrying only one of the alleles more easily either loose or gain weight, whereas individuals with the other allele have a more stable BMI. The difference in variance observed for the FTO variant has been suggested to be due to different responses to activity levels and other lifestyle factors (11, 12) . A number of vSNPs have also been identified for two cardiovascular protein biomarkers (CRP and ICAM-1) (13) , where part of the difference in variance was suggested to be explained by interactions with BMI or smoking. This suggests that the risk of an obesity-, or smoking-associated cardiovascular event differs between individuals, and that certain genetic compositions could increase the tolerance to cardiovascular risk factors.
In the context of DNA methylation, vSNPs are associated with variability in DNA methylation levels, where one allele is associated with greater variance compared to the other. DNA methylation levels are to a large fraction determined by genetic variants (4) and are therefore optimal phenotypes for studying vSNPs. In addition, DNA methylation levels can be measured across the genome resulting in hundreds of thousands of phenotypes for a more precise estimation of the occurrence of vSNPs in the human genome. DNA methylation variability might be linked to molecular responses to environmental stimuli, and previous studies have suggested that such vSNPs could increase epigenetic plasticity or even explain part of the hidden heritability behind complex traits (14) . For example, individuals with a certain genotype can be at greater risk for disease in response to certain environmental factors, which can be mediated by gene Â environment interaction effects on DNA methylation levels.
The human genome consists of over three billion base pairs, organized in blocks with high linkage disequilibrium (LD). Each such block contains genetic variants that have co-segregated during evolution with low rate of recombination within blocks (15) (16) (17) . Therefore, nearby genetic variants that regulate the same gene are often, to some extent, in LD with each other.
This can result in a cryptic pattern of phenotypic variance heterogeneity between genotypes that is not due to biological interactions, but rather to the LD between genetic variants that influence the same phenotype (18) . Therefore, one needs to carefully consider the effect of nearby SNPs that influences the mean phenotypic value, when investigating vSNPs.
In this study, we have investigated the number of genetic loci that potentially interact with other loci or environmental factors by identifying vSNPs in the human genome. We first identified vSNPs across the human genome. We then evaluated the potential of each vSNP to represent underlying gene Â gene or gene Â environment interactions by performing additional analyses to eliminate vSNPs that reflects statistical artifacts.
Results
In this study, we have used data from a population-based cohort ranging in age from 14 to 94. Participants were ascertained independent on health status and no information on previous disease history has been included in this study. A total of 431 813 autosomal CpG sites passed quality control (QC) in 729 individuals (341 males and 388 females) with genome-wide genotype data available for over 10 million SNPs.
Identification of vSNPs across the genome
To determine the occurrence of vSNPs in the human genome, we analyzed DNA methylation levels at 431 813 CpG sites (Fig. 2) . As many as 530 365 222 pairwise tests were performed using 3 429 873 SNPs (minor-allele frequency, MAF ! 10%) located within 500 kb from respective CpG site. Adjusting for multiple testing, using Bonferroni method, resulted in 374 252 CpG-vSNP pairs (P< 9.427 Â 10
À11
). These represented 229 746 unique vSNPs (6.9% of all investigated SNPs) that were associated with variance in DNA methylation at a CpG site. However, many vSNPs were associated with DNA methylation variance at the same CpG site, due to LD between the SNPs. This brings the number of CpG sites with at least one associated vSNP down to 7195 CpG sites (Fig. 2 , Supplementary Material, Table S1 ). Most CpG-vSNP pairs were in close proximity (Fig. 3A) with a distance between the most significant vSNP and respective CpG site of less than 250 kb for 95% of the CpG-vSNP pairs. This justifies that we only search for vSNPs within 500 kb from each CpG site. As sensitivity analysis, we also estimated the rate of vSNPs in the subset of SNPs (N ¼ 166 920) that were directly genotyped instead of derived from the imputed data. This resulted in Figure 1 . Examples of distributions for two quantitative traits that differ in: (A) mean value between three groups, and (B) variance between three groups. The groups can represent individuals with three different genotypes in a biallelic marker (e.g. SNP). In (A), the variance of all groups is identical (variance ¼ 1) and the mean values are 0, 0.5 and 1 for the black, red and blue distributions, respectively. In (B), the mean values are 0 in all distributions, and the variances are 1, 1.5 and 2 for the black, red and blue distributions, respectively.
10 340 vSNPs (6.2% of all genotyped SNPs investigated), which is a very similar fraction as from the imputed data presented earlier. We also re-calculated the variance heterogeneity using Leven's test and non-transformed DNA methylation levels for the 7195 genome-wide significant vSNPs. This resulted in that 74% of the vSNPs got even more significant P-values and only 26% were less significant P-values (Supplementary Material, Table S1 ). However, 86% of the vSNPs still reached the threshold of genome-wide significance when using Leven's test.
Occurrence rate of vSNPs vs. SNPs with mean effects (mean-effect SNPs)
To determine to what extent DNA methylation is being influenced by vSNPs, in relation to being associated with SNPs that affect the mean DNA methylation levels, hereafter referred to as mean-effect SNPs, we also performed association studies to identify SNPs with mean effects on DNA methylation levels. To make the occurrence rates comparable, the same strategy was used as for identifying vSNPs: with 530 365 222 pairwise tests using 3 429 873 SNPs and 431 813 CpG sites. These analyses revealed that for 52 335 CpG sites, mean-effect SNPs were identified. This is more than seven times higher as compared to the number of CpG sites (N ¼ 7195) for which a vSNP was associated with variance heterogeneity.
Identification of mean-effect SNPs influencing variance heterogeneity
Next, we evaluated if the variance heterogeneity, identified for the most significant vSNPs, could be explained by additional linked mean-effect SNPs. We performed association tests for each of the 7195 CpG sites. As previous, we first tested SNPs located within a region of 500 kb from each CpG site. For a majority of the CpGs (N ¼ 7083) we identified a significant meaneffect SNP, using a standard GWAS P-value cut-off of P ¼ 5 Â 10
À8
. Extending the region in which we searched for the mean-effect SNP to the whole chromosome resulted in another nine CpG sites with a significant mean-effect SNP (Supplementary Material, Table S1 ). For a subset of the CpG sites (N ¼ 103), we did not observe any significant mean-effect SNPs on the same chromosome. For these sites, we performed association analyses across the whole genome (see below).
Adjusting for mean-effect SNPs
For each of the 7092 CpG sites with an associated vSNP and a significant mean-effect SNP on the same chromosome ( Fig. 2) , we tested for variance heterogeneity after adjusting for the most significant mean-effect SNP. This resulted in 6140 CpG sites for which the variance heterogeneity was no longer significant (Supplementary Material, Table S1 ). The distance between these mean-effect SNPs and respective CpG site showed a similar distribution as the vSNPs (Fig. 3A) . These results show that for a majority (85%) of the vSNP-CpG pairs, the variance heterogeneity could be explained by one additional linked nearby mean-effect SNP. This effect is referred to as a statistical artifact, which is defined as the difference in phenotypic variance that is due to the LD with genetic variants with mean effects on the phenotypic trait. Interestingly, the MAF for the mean-effect SNPs tend to be lower compared to the vSNPs with a positive correlation (R 2 ¼ 0.16) between the pairwise MAFs (Fig. 3B ).
There is also a strong LD between the vSNP and respective mean-effect SNP ( Fig. 3C) 
Conditional analyses to identify mean-effect SNPs
For CpG sites, where the vSNPs were still associated with variance heterogeneity after adjusting for the top mean-effect SNP, we broadened the search to include four conditional SNPs per CpG site (Supplementary Material, Table S1 ). We then regressed out all variance explained by the previous mean-effect SNP and the four additional SNPs and tested for variance heterogeneity between genotypes of the respective vSNP. This resulted in a number (N ¼ 487) of remaining CpGs with significant variance heterogeneity, and a similar number of CpGs (N ¼ 465), for which variance heterogeneity between genotypes was no longer detectable. The vSNPs for which the variance heterogeneity did not appear to be completely explained by additionally linked SNPs are possible candidates to represent biological interactions. Only for eight CpG sites, as many as four significant (using a standard GWAS P-value cut-off of P ¼ 5 Â 10 À8 )
conditional mean-effect SNPs were identified (Supplementary Material, Table S1 ), which justified for not continuing identifying additional mean-effect vSNPs.
Genome-wide mean-effect SNPs, gene Â environment and gene Â gene interactions
For the 103 CpGs, where no mean-effect SNP could be found on the same chromosome ( Fig. 2 ), we performed a genome-wide search for mean-effect SNPs. For 17 of these 103 CpG sites, such mean-effect SNPs were identified but variance heterogeneity was still significant after adjusting for respective mean-effect SNPs. We also performed interaction analyses for the 590 (103 þ 487) CpG sites with significant variance heterogeneity after adjusting for all conditional mean-effect SNPs above ( Fig. 2 ). First, we included an interaction term between the vSNP and each of the covariates (sex, age, smoking and cell composition). This resulted in significant (after adjusting for 590 CpG sites and 9 interaction terms) interactions for 14 of the 590 CpG sites. For three of these, the vSNP interacted with age and the others with cell composition. However, after adjusting for the interaction term, variance heterogeneity was still observed for all but two vSNPs.
Rare genetic variants with mean effects on DNA methylation
The results from the conditional analyses show that the vSNP alleles that are associated with larger variance often are associated with rare genetic variants with mean effects on DNA methylation levels (Supplementary Material, Table S1 ). For 11 CpG sites, the variance heterogeneity could be explained by 1 single rare (MAF < 1.7%) mean-effect SNP ( Table 1 ). Out of these 11 rare SNPs, 5 were also present in the GTEx dataset (V7). Four of them were associated with the expression of a nearby gene in whole blood: rs75988514 with CRACR2B (¼1.60087E-08), rs144630985 with LETM1 (P ¼ 0.00663735), rs72916665with an antisense RNA gene-AP000442 (P ¼ 0.00944207) and rs144222017 with ZDHHC11B (P ¼ 0.00435541). The fifth SNP (rs372060464) was not associated with a known gene in whole blood, but with the expression of ARHGEF16 in Oesophagus-Mucosa (P¼ 0.0000039) Another example if rare variants is for the CpG site cg15718932, which is located within the guanylate binding protein 2 interferon-inducible gene (GBP2). For this site, we identified four independent SNPs (rs2182322, rs183183990, rs28417438 and rs61766153 with frequencies 0.038, 0.026, 0.032 and 0.037, respectively) that influence the mean DNA methylation level (Supplementary Material, Table S1 ). Together, these SNPs explain all apparent variance heterogeneity seen between genotypes of the vSNP rs4656076. By constructing haplotypes for the five SNPs above (the vSNP and the four independent meaneffect SNPs), we found that there are six common haplotypes that represent more than 99% of all haplotypes in the cohort (Table 2) . It can clearly be seen that the G-allele of the vSNP always is found on the haplotype carrying the major allele of all the four other SNPs (Table 2 ). This means that individuals with the G-allele in the vSNP have no haplotype variability. In contrast, individuals carrying the C-allele in the vSNP display five different haplotypes, each with different mean DNA methylation levels (Fig. 4) . This is in agreement with the C-allele being associated with 49% larger variance (Supplementary Material, Table S1 ) in DNA methylation compared to the G-allele.
Replication of previously identified vSNPs
A previous study has identified three vSNPs to be associated with difference in DNA methylation variance (19) . One of these vSNPs was associated with two different CpG sites bringing the number of vSNP-CpG pairs to four. In order to make our results comparable to the previous publication, we did not ranktransform the DNA methylation values prior to these analyses. We confirmed the mean effects for each vSNP and confirmed that the suggested vSNPs are also associated with DNA methylation variance heterogeneity (Table 3 , Fig. 5 ).
Next, we determined whether the observed variance heterogeneity was due to biological interactions via gene Â gene, or gene Â environment interactions, or if this heterogeneity was due to the confounding effects of additional linked variants, and rather represented statistical artifacts. We performed a GWAS for each of the four CpG sites presented in Figure 5 , to identify SNPs with mean effects on DNA methylation levels. For all four CpGs, such mean-effect SNPs were identified, and the top SNPs were found to be located in the proximity to the respective vSNP (Table 3) .
We calculated LD between the vSNPs and their respective top mean-effect SNP. The correlation was modest for all pairs (R 2 <¼ 0.41). However, with regards to Lewontins D 0 , the vSNPs and the respective top mean-effect SNP was in more or less complete LD (D 0 > 0.99) for all pairwise SNPs (Table 3 ). The high D 0 in combination with a low R 2 value suggests that the allele frequencies of the top GWAS SNPs are not equal to the frequencies of the respective vSNP. This follows because D 0 is a measure that summarizes the evidence for historical recombination between two loci whereas R 2 is squared correlation coefficient between the loci. We can clearly see that in the subset of individuals carrying the C allele (the allele with greatest variance) in a vSNP, the corresponding top mean-effect SNP is polymorphic, whereas the subset of individuals with the other allele in the vSNP is not polymorphic for the corresponding meaneffect SNP (Table 4) . By including the mean-effect SNPs as covariates in the models, the variance heterogeneity between the genotypes in the previously identified vSNPs was reduced dramatically (Table 3) . This suggests that a large fraction of the observed variance heterogeneity was indeed due to statistical artifacts. We created DNA methylation beta residuals by regressing out, i.e. adjusting for, all covariates in addition to the respective mean-effect SNP (see Materials and Methods section). The distribution of beta residuals now seems to be more similar between genotypes in respective vSNPs (Fig. 6 ), compared to when the respective mean-effect SNPs were not adjusted for (Fig. 5) . In contrast to previously presented results, there is now only a small detectable difference in variance between vSNP genotypes (Table 3) .
To see if we could find any gene Â gene interactions that would account for the observed variance heterogeneity, we repeated the genome-wide scan in order to identify genetic variants that interact with the three vSNPs. We identified highly significant statistical interactions for all vSNPs with P-values down to 7.7 Â 10 À97 (Table 3 ). The interacting SNPs do not seem to be in strong LD with the vSNPs neither with regards to R 2 nor
The interactions can be visualized as individuals carrying the T/T genotype in the vSNP rs3130320, showing no mean effect on DNA methylation levels at cg25949002 by the interacting SNP (rs9279550), whereas individuals carrying the C/C genotype in the vSNP show a strong mean effect by rs9279550 on DNA methylation levels (Fig. 7A) . Interestingly, this interaction was no longer significant if the mean-effect SNP (Table 3) was also included as a covariate in the model. Similarly, by using the DNA methylation beta residuals, where all variance that could be attributed to the mean-effect SNP (rs9368716) for cg25949002 was regressed out, the previously detected interaction effect was dramatically reduced in size (Fig. 7B ) and was no longer significant (Table 3 ). This suggests that the observed statistical interactions are statistical artifacts introduced when not considering the mean effect by the highly significant mean-effect SNPs that are in LD with the vSNPs. This suggests that the observed statistical interactions are indeed statistical artifacts rather than biological interactions. Such artifacts instead represent mean-effect SNPs that are in LD with the vSNPs. In agreement with this, the mean-effect SNPs were also in high LD, with regards to D 0 , with the respective interacting SNP for all four CpG sites (Table 3) .
Discussion
The aim of this study was to identify and quantify the extent of vSNPs in the human genome. We replicated three previously identified vSNPs, showing that the vSNPs were indeed associated with variance heterogeneity in DNA methylation levels. In addition, we could identify SNPs that showed statistically significant interactions with all three vSNPs. However, we also showed that variance heterogeneity for these vSNPs is not due to biological interactions. Instead the difference in variance is driven by additional mean-effect SNPs in complete LD with the respective vSNPs. This means that the apparent variance heterogeneity and also the statistically significant interactions are statistical artifacts caused by additional linked SNPs with mean effects on DNA methylation levels. We therefore conclude that some of the previously suggested vSNPs (19) do not represent 
Notes:
In the examples shown above, the variance heterogeneity is to a major part caused by one single rare (MAF < The median, first and third quartiles for DNA methylation levels (untransformed values) for the different genotypes of the mean-effect SNP.
biological interactions, but rather statistic artifacts. This suggests that more careful evaluations need to be performed when evaluating potentially interacting genetic variants. A previous study, on Arabidopsis thaliana, suggested that vSNPs are as common as SNPs with mean effects on phenotype mean (8), i.e. the type of SNPs that are commonly identified in GWAS. Our results show that this is not the case in the human genome. The number of CpG sites with a vSNP is about seven times lower than that of CpG sites with an SNP associated with phenotypic mean in our data. In addition, the vast majority of the vSNPs identified represent statistical artifacts rather than biological interactions, which agrees with previous studies (18) . These results suggest that vSNPs are not likely to explain any substantial portion of the heritability of complex traits.
Despite the low frequency of potential biological vSNPs identified in our study, vSNPs reflecting true interactions have previously been reported. The FTO variant rs7202116 (11) is associated with a 7% difference in variance between individuals homozygous for different alleles. Another FTO SNP (rs9939609) in LD with rs7202116 has been shown to interact with physical activity on BMI (20) . Therefore, the 590 vSNPs that we identified and for which the variance heterogeneity could not be explained by any additional linked SNP may potentially reflect biological interactions. However, we were unable to identify any gene Â environment interactions that could explain those observations, possibly due to lack of environmental variables investigated. We did not continue to search for potential gene Â gene interactions partly due to the low statistical power for identifying gene Â gene interactions in a cohort with somewhat limited sample size.
We have highlighted one vSNP, rs4656076 (Fig. 4 , Table 2 ) in our study, for which all variance heterogeneity was due to rare genetic variants with significant mean effects on DNA methylation. Similarly, many other vSNPs show the same pattern with one of the vSNP alleles being located on one major haplotype, while the other allele (the one associated with higher DNA methylation variance) being located on several, less frequent haplotypes. This indicates that some of the variance heterogeneity is due to the enrichment of less-frequent mean-effect SNPs in LD with one of the vSNP alleles. It is well-known that Figure 4 . Boxplot of DNA methylation levels for the different haplotypes. Haplotype #6 is the most common haplotype and carries the G allele in the vSNP, the allele that is associated with lower variance compared to the C allele. In (A), the haplotypes with a G in the vSNP is compared to all combined haplotypes with a C in the vSNP. In (B), the haplotypes with a G in the vSNP is compared to each of the haplotypes with a C in the vSNP. Only individuals being homozygous for the C or G allele in the vSNP is included in these analyses. 
Notes: All four independent SNPs are in LD (D 0 ¼1) with the vSNP, which can be seen by the minor allele of these four SNPs co-segregate with the C allele in the vSNP.
Similarly, all the independent SNPs are in LD (D 0 ¼1) with each other's, which can be seen by the minor allele in each SNP always co-segregate with the major allele of the other SNPs. R 2 is low (<0.2) for all SNP pairs.
the genome can be divided into haplotype blocks (15, 16) . These haplotype blocks represent chromosomal regions that have been inherited together without any recombination between the nucleotides in the block. It has also been demonstrated that individual haplotype blocks that have been subjected to natural selection (21, 22) can show a deviating pattern of genetic variants. However, the co-segregation, or lack of co-segregation, of rare causal variants has not been extensively studied. It is well-known that imputation methods perform worse for rare genetic variants and it is therefore likely that sequence data would show even higher haplotype diversity for some vSNP alleles. It is therefore probable that some of the CpG sites, for which we do not find any genetic variants to explain the observed variance heterogeneity, actually reflect the accumulation of rare genetic variants that are not present in imputed/ genotyped data, or due to poor imputation quality. We therefore propose that identifying vSNPs may be a method for identifying genomic regions with rare unmeasured alleles with phenotypic effects. In the vSNP scan, we used a MAF threshold of 10%. SNPs with lower MAF would result in small genotype groups and decreased power of detecting variance heterogeneity. Since incomplete LD, often associated due to difference in MAF, between the vSNP and the mean-effect SNP results in variance heterogeneity, it is however possible that our search for meaneffect SNPs is biased toward SNPs with low MAF.
We chose to use Bartlett's test to identify vSNPs. There are a number of other tests that could have been as appropriate. For example, Levene's test is more stable to non-normalized data compared to Bartlett's test (9, 23) . However, the computations are much more time consuming for Levene's test and considering the large number of tests performed in this study, Bartlett's test was preferable. Instead we rank transformed the data prior to analyses, which justifies our use of Bartlett's test. However, for the genome-wide significant vSNPs we repeated the analyses using Levene's test, which showed that most of the vSNPs (86%) were still genome-wide significant independent on which test used.
In summary, we have shown that the variance heterogeneity originally attributed to vSNPs mainly represents statistical artifacts rather than gene Â gene or gene Â environment interactions. These results contradict the hypothesis that vSNPs could explain a significant part of the hidden heritability. However, the underlying hypothesis of vSNPs and their possible role in phenotypic plasticity is certainly still of interest. Our results demonstrate that careful validation is required to accurately assign and interpret vSNPs. DNA methylation phenotypes are perfect for studying the phenomenon of variance heterogeneity since DNA methylation is among the human phenotypes most strongly associated with genetic variants. We have therefore been able to identify multiple independent genetic effects using a limited but homogeneous sample. When study cohorts increase in sample size, the power to identify vSNPs for other phenotypes increases. It is therefore important to consider the possible influence of other linked genetic variants on the phenotypic heterogeneity between genotypes to avoid misleading interpretations.
Materials and Methods

Study cohort: the Northern Sweden Population Health Study (NSPHS)
The study cohort in this project (NSPHS) was a health survey of the population in the parishes of Karesuando (year 2006) and Soppero (year 2009) county of Norrbotten and was initiated to study medical consequences of lifestyle and genetics. For each participant (N ¼ 1069), blood samples were taken and immediately frozen and stored at À70 C. Genomic DNA for methylation analyses was extracted from previously frozen peripheral blood leukocytes using a phenol: chloroform protocol. More information about the NSPHS has been published previously (24) . The NSPHS study was approved by the local ethics committee at the Uppsala University (Regionala Etikprö vningsnä mnden Uppsala Dnr 2005: 325) in compliance with the Declaration of Helsinki. All participants gave their written informed consent to the study including the examination of environmental and genetic causes of diseases. In case the participant was not of legal age, a legal guardian signed additionally.
Genetic data
For each participant, blood samples were taken and stored at À70 C and DNA has been extracted from whole blood for genetic and epigenetic analyses. DNA samples from the NSPHS individuals have been genotyped using the Illumina HumanExome-12v1 and either Illumina Infinium HumanHap300v2.0 or Illumina HumanOmniExpress-12v1 bead microarrays (7). Un-assayed genotypes were imputed using the 1000 Genome Project reference panel. Analysis of genotype raw data and QC were performed using the GenABEL package (25) . Genotype data were imputed with a pre-phasing approach implemented in SHAPEIT version 2.5 (r790) (26) and IMPUTE2 (version 2.3.2) (27) in the two subcohorts (year 2016 and 2009) separately using the 1000 Genomes Phase 3 integrated variant set (released on October 2014) as the reference panel. QC of imputed data was performed using GTOOL (v0.7.5). First IMPUTE's 'info' score >0.3 were required in both sub-cohorts prior to merging. The merged data were filtered using a Bonferroni-corrected Hardy-Weinberg cut-off of 0.05 combined info score >0.3 and a MAF > 0.001 corresponding to at least one chromosome in the whole material. After QC of imputed autosomal data 11 901 484 SNPs and a total of 1033 individuals remained.
DNA methylation data
Genomic DNA for 743 samples was bisulfite-converted using an EZ DNA methylation Kit (ZYMO research) according to the manufacturer's recommendations. The methylation status of the genomic DNA was then assessed using the Human Methylation450 BeadChip (Illumina, San Diego, USA) according to the standard protocol. Analysis of the raw data was performed using minfi. Normalization was done using Subsetquantile Within Array Normalisation (SWAN). A marker detection P-value 1.38 * 10 À10 (Bonferroni adjusted P-value ¼ 0.05 Table 3 . Association between SNPs and mean DNA methylation levels
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Top GWAS SNPs adjusted for the number of individuals * the number of CpG sites analyzed) was applied. A probe call rate of >0.98 and an individual call rate of >0.98 was used. After removing control samples (28) and two ethical outliers 729 samples (all of which had passed the QC in the SNP genotyping) with DNA methylation data remained. All CpG sites with probes that has been suggested to cross hybridize (29) were removed and we only considered autosomal CpG sites in the analyses leaving 431 813 sites.
Pre-processing of DNA methylation values
To ensure that the results were not influenced by variation in blood cell fractions between samples, we estimated the fraction of CD8T-, CD4T-, NK-and B-cells monocytes and granulocytes in the study samples. This was done using the R package minfi that allows for estimating cell fractions in Illumina 450K methylation data from whole blood. This method is based on the methylation data published for flow-sorted cells (30) and algorithms derived from the study by Houseman et al. (31) . Prior to analyses, DNA methylation levels were rank transformed to obtain approximately normally distributed variables using inverse normal transformation as implemented in the rntransform function in the R library GenABEL. These values were then adjusted for covariates (covariate effects were regressed out) including sex, age, smoking status, cell fractions (CD8T-, CD4T-, NK-, and B-cells, monocytes and granulocytes) and plate effects (batch and array) again using the rntransform function.
Identification of vSNPs at a genome-wide level
In order to get large enough genotype groups, we only investigated SNPs with MAF greater than 10%. The variance in DNA methylation for CpG sites on the Illumina DNA methylation chip were compared between genotypes for all SNPs within 500 kb from the CpG site. Imputed genotype data was used and prior to these analyses, dosage values were assigned to genotypes so that a dosage value of 0-0.1 represents 0 copies of the minor allele (homozygous for major allele), 0.9-1.1 represents 1 copy of the minor allele (heterozygous) and >1.9 represents 2 copies of the minor allele (homozygous for the minor allele). Genotypes with dosage values that did not fall into theses ranges were set a missing. Before comparing the variance between genotypes, the variance due to all covariates was regressed out (adjusted for) and the residuals were inserted into the models (see Pre-processing of DNA methylation values section). We used Bartlett's test to identify variance heterogeneity between genotypes. This tests for deviation from the null hypothesis that the variance in DNA methylation is equal between groups. In this approach, all three genotypes: homozygous for the minor allele, homozygous for the major allele and heterozygous were compared to each other using the bartlett.test function in the stats R-package. Genotypes with less than 10 individuals were set to missing, and for such SNPs only two genotypes were compared (homozygous for the major allele, and heterozygous). A total of 530 365 222 test were performed resulting in threshold for significance of P ¼ 9.43* 10 À11 using
Bonferroni adjustment for multiple testing. We also repeated the analyses for all genome-wide significant vSNPs using Leven's test for homogeneity of variance using the leven.test function in the Rcmdr R-package. The DNA methylation values were pre-processed as previously but without the rank transformation since Levene's test is more stable to non-normalized data. To compare the relative number of significant vSNPs associated with variance heterogeneity in DNA methylation to the number of SNPs with mean effects on DNA methylation levels, i.e. SNPs that influence the mean value, we repeated the analyses above and tested for equality of the mean DNA methylation level between genotypes using Welch's ANOVA that adjust for heteroskedasticity. This was done using the oneway.test in the stats R-package.
Association studies to identify SNPs with mean effects
For CpG sites where a significant vSNP was identified, we performed association analyses to identify SNPs with a mean effect on DNA methylation. In the primary analysis, only SNPs within 500 kb from the CpG site were considered and the same covariates as above were regressed out prior to analyses. In contrast to previous analyses, all SNPs, independent on genotype frequency, were analyzed using an additive genetic model. More distantly located mean-effect SNPs and conditional SNPs were identified by instead considering the entire chromosome as a potential region for association. Conditional SNPs were identified by repeating the association analyses five times, first conditioning on the primary mean-effect SNP to identify a first conditional SNP, then conditioning on the primary and first conditional SNP to identify a second conditional SNP and so on. To verify that the rare variants with mean effects on DNA methylation, also have effects in an independent sample, we downloaded used data from the GTEx-project (32) . Every SNP-gene association test (including non-significant test) were downloaded from the GTEx portal (v7 release, accessed on December 10, 2017) and matched to the mean-effect SNPs by chromosome and position (Build 37). Since the DNA methylation data was measured in whole blood, we used the GTEx data for whole blood to evaluate the effect of our SNPs RNA levels.
Haplotype inference and LD
LD (Lewontins D 0 , and the correlation coefficient) was calculated using the LD function in the genetics R-library. Haplotypes for vSNPs and mean-effect SNPs were estimated using the haplo.stats library for haplotype inference. Nine individuals were removed from haplotype analyses, due to low posterior probability (<0.99) for the haplotypes and another nine individuals were removed because they displayed rare haplotypes (<0.5%).
Association, heterogeneity and interaction test for candidate vSNPs
Previously suggested vSNP-CpG pairs were selected from a previous publication (19) . Density plots were constructed using a Gaussian kernel with bandwidth ¼ 'nrd0' (default). Variance heterogeneity was tested using Bartlett's test with the null hypothesis that the variance in DNA methylation is equal among all three groups of individuals with different genotypes in the vSNPs, and with the alternative that the variance differs in at least one of the groups. GWAS for each of the four CpG sites were performed using a linear regression model (additive model) and included all SNPs that passed QC. Interactions between the vSNPs and all other SNPs were identified by performing a genome-wide scan. For each SNP, a linear model, including the interaction term vSNP Â SNP was tested. We evaluated the estimate of the coefficient (b) for the interaction term and tested if this estimate significantly deviated from zero. The null hypothesis H 0 : b ¼ 0 was either accepted or rejected, depending on the outcome of a marginal student's t-test, which in this case (i.e. one degrees-of-freedom difference between the nested models and normal regularity conditions) is equivalent to a likelihood-ratio test (or partial F-test) of the hypothesis that the interaction term is redundant. DNA methylation levels adjusted for covariates on their original scale (not rank transformed) were used in all statistical analyses for theses candidate vSNPs. To test if the significance of the interaction and variance heterogeneity remained after adjusting for the most significant mean-effect SNP, the DNA methylation values were further adjusted for this SNP similarly to the genome-wide analyses above.
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